Skip to content
Homepage
Author:
Senzime
Posted Date:
June 29, 2026
Senzime’s TetraGraph System Receives ANVISA Regulatory Approval in Brazil
Senzime
June 29, 2026
Senzime to Showcase Expanded TetraGraph Capabilities with Launch of TetraAnalytics at Euroanaesthesia 2026
Senzime
June 5, 2026
Senzime Strengthens Position in Pediatric Anesthesia by Securing Another Hospital Contract and Highlighting Positive Outcome Data
Senzime
June 3, 2026
Senzime Advances Sustainable Anesthesia Monitoring with Launch of New EMG Sensor
Senzime
June 1, 2026
From Science to Practice: Senzime Obtains FDA 510(k) Clearance for Enhanced TetraGraph System
Senzime
May 29, 2026
Bulletin From Annual General Meeting in Senzime AB (publ)
Senzime
May 28, 2026
Senzime Strengthens U.S. Operations with New Leadership Appointments
Senzime
May 25, 2026
Senzime’s TetraGraph System Contracted on Three Leading GPO Agreements in the US
Senzime
May 25, 2026
Senzime Publishes Annual and Sustainability Report for 2025
Senzime
May 25, 2026
Margins Strengthened and Cash Flow Improved Despite a Temporary Dip in The Growth Trajectory. Full-Year Targets Remain on Track
Senzime
May 24, 2026
1
2
Next
